These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 21419539)

  • 21. Do provincial drug benefit initiatives create an effective policy lab? The evidence from Canada.
    Pomey MP; Morgan S; Church J; Forest PG; Lavis JN; McIntosh T; Smith N; Petrela J; Martin E; Dobson S
    J Health Polit Policy Law; 2010 Oct; 35(5):705-42. PubMed ID: 21123668
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Case study on nutrition labelling policy-making in Canada.
    Vogel EM; Burt SD; Church J
    Can J Diet Pract Res; 2010; 71(2):85-92. PubMed ID: 20525420
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Relationship between evidence and policy: a case of evidence-based policy or policy-based evidence?
    Hunter DJ
    Public Health; 2009 Sep; 123(9):583-6. PubMed ID: 19748107
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Political and legal institutions and their influence on drug policy: an Australian perspective.
    Ryder D
    Drug Alcohol Rev; 2008 Jul; 27(4):374-9. PubMed ID: 18584386
    [TBL] [Abstract][Full Text] [Related]  

  • 25. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.
    American Society of Clinical Oncology
    J Clin Oncol; 2003 Jun; 21(12):2397-406. PubMed ID: 12692171
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Implementation of a government policy programme on Operation Kvinnofrid.
    Häggblom AM; Möller AR
    Nurs Inq; 2009 Mar; 16(1):43-52. PubMed ID: 19228303
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evidence-based decision-making within Australia's pharmaceutical benefits scheme.
    Lopert R
    Issue Brief (Commonw Fund); 2009 Jul; 60():1-13. PubMed ID: 19639714
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Notes from the laboratories of democracy: state government enactments of market- and state-based health insurance reforms in the 1990s.
    Barrilleaux C; Brace P
    J Health Polit Policy Law; 2007 Aug; 32(4):655-83. PubMed ID: 17639016
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Amendment of tuberculosis prevention law and prospect of tuberculosis control program].
    Ushio M
    Kekkaku; 2005 Jul; 80(7):541-6. PubMed ID: 16167781
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The influence of professional values on the implementation of Aboriginal health policy.
    Lloyd J; Wise M; Weeramanthri T; Nugus P
    J Health Serv Res Policy; 2009 Jan; 14(1):6-12. PubMed ID: 19103911
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluating the sub-national fidelity of national Initiatives in decentralized health systems: Integrated Primary Health Care Governance in Nigeria.
    Eboreime EA; Abimbola S; Obi FA; Ebirim O; Olubajo O; Eyles J; Nxumalo NL; Mambulu FN
    BMC Health Serv Res; 2017 Mar; 17(1):227. PubMed ID: 28327123
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The role of evidence and the expert in contemporary processes of governance: the case of opioid substitution treatment policy in England.
    Duke K; Thom B
    Int J Drug Policy; 2014 Sep; 25(5):964-71. PubMed ID: 24582381
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Is pharmaceutical policy evidence-informed? A case of the deregulation process of nicotine replacement therapy products in Finland.
    Kurko T; Silvast A; Wahlroos H; Pietilä K; Airaksinen M
    Health Policy; 2012 May; 105(2-3):246-55. PubMed ID: 22417863
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An exploratory study identifying where local government public health decision makers source their evidence for policy.
    Stoneham M; Dodds J
    Health Promot J Austr; 2014 Aug; 25(2):139-42. PubMed ID: 25200469
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ensuring the policy relevance of population health research: experiences from the Drug Policy Modelling Program.
    Ritter A
    N S W Public Health Bull; 2011 Apr; 22(1-2):19-22. PubMed ID: 21527076
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Informing public health policy through deliberative public engagement: perceived impact on participants and citizen-government relations.
    Molster C; Potts A; McNamara B; Youngs L; Maxwell S; Dawkins H; O'Leary P
    Genet Test Mol Biomarkers; 2013 Sep; 17(9):713-8. PubMed ID: 23862565
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prospective analysis of the development of the national nutrition agenda in Vietnam from 2006 to 2008.
    Lapping K; Frongillo EA; Studdert LJ; Menon P; Coates J; Webb P
    Health Policy Plan; 2012 Jan; 27(1):32-41. PubMed ID: 21330309
    [TBL] [Abstract][Full Text] [Related]  

  • 38. What counts and how to count it: physicians' constructions of evidence in a disinvestment context.
    Hodgetts K; Elshaug AG; Hiller JE
    Soc Sci Med; 2012 Dec; 75(12):2191-9. PubMed ID: 22963922
    [TBL] [Abstract][Full Text] [Related]  

  • 39. An Australian approach to the policy translation of deliberated citizen perspectives on biobanking.
    Molster C; Maxwell S; Youngs L; Potts A; Kyne G; Hope F; Dawkins H; O'Leary P
    Public Health Genomics; 2012; 15(2):82-91. PubMed ID: 22179074
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Strengthening advocacy efforts with empirical evidence: A case example of the conduct, uptake and utilisation of research in drug policy decision-making in Vietnam.
    Vuong T; Ritter A; Nguyen N; Ali R
    Int J Drug Policy; 2017 Nov; 49():41-47. PubMed ID: 28910608
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.